Your CDMO specialized in ex-vivo and in-vivo lentiviral vectors
Making the medicine of the future a reality
With expertise in virology, we tailor solutions to meet specific requirements of your lentiviral vector for both ex-vivo and in-vivo administration.
Business model
GMP CDMO focused on different stages of the process.
Specialization
We work exclusively in lentivirus, offering comprehensive services.
Customized service
Technical adaptation and timely slot availability for each project.
Quality and regulatory
Compliance with EMA and FDA regulatory requirements.
Vivebiotech in data
-
+50 clients
in the US, Europe, Asia and Australia -
10 years
of lentiviral vectors experience
-
+ 180 batches manufactured in bioreactor
+ 60 batches in reactor per year
+ 10 in-vivo programs
In 7 dedicated cleanrooms
-
+ 140 people
combining young talent and experience
Our clients locations
About us
We are a Contract Development and Manufacturing Organization (CDMO) with over 50 biotech and pharmaceutical companies worldwide that have placed their trust in us.
Our value
VIVEbiotech is one of the only companies in the world specialized exclusively in lentiviral vectors. One of the things that sets us apart is our expertise not only in production but also virology, backed by a team of professionals with more than 30 years of experience.
Last news